SCC Soft Computer is Proud to Announce the Development of the SoftBank Interface to the Alloantibody Exchange

June 16, 2022

In collaboration with industry experts, SCC Soft Computer is developing an interface directly to the Alloantibody Exchange, with the goal to increase transfusion safety by improving shared patient antibody information between various facilities. https://www.alloantibody.org

SCC’s SoftBank® application will query the registry to augment patient antibody information with antibodies identified by other facilities, eliminating potential transfusion reaction. The application will also provide patient antibody testing results to the registry so they may be shared with other facilities.

Expected timeline for SCC’s SoftBank® interface development planned for 2022.


Return to SCC News